Bisphosphonates in the renal patient

Review

John Cunningham. Nephrol Dial Transplant. 2007 Jun.

. 2007 Jun;22(6):1505-7.

doi: 10.1093/ndt/gfm217.

No abstract available

Comment on

Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease.
Kikuchi Y, Imakiire T, Yamada M, Saigusa T, Hyodo T, Kushiyama T, Higashi K, Hyodo N, Yamamoto K, Suzuki S, Miura S. Kikuchi Y, et al. Nephrol Dial Transplant. 2007 Jun;22(6):1593-600. doi: 10.1093/ndt/gfl568. Epub 2006 Oct 13. Nephrol Dial Transplant. 2007. PMID: 17041001 Clinical Trial.
Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).
Fujii N, Hamano T, Mikami S, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Imai E, Hori M, Ito T. Fujii N, et al. Nephrol Dial Transplant. 2007 Jun;22(6):1601-7. doi: 10.1093/ndt/gfl567. Epub 2006 Nov 23. Nephrol Dial Transplant. 2007. PMID: 17124283 Clinical Trial.